Discover how the final rule from the CDC expands access to the World Trade Center (WTC) Health Program, now including Pentagon and Shanksville responders. This course unpacks the statutory changes, capped at 500 new enrollees, detailing the impact and compliance with...
Nonprescription Drug Products: Navigating New FDA Conditions
$19.99
This course provides an in-depth look at the FDA’s final rule for nonprescription drugs that have an Additional Condition for Nonprescription Use (ACNU). Participants will learn about the critical application, labeling, and postmarketing requirements. The course also explains the reasons behind the delayed implementation date and how this impacts stakeholders.
In this course you will learn the following:
* Understand the purpose and scope of the final rule on nonprescription drug products with an ACNU.
* Identify the key requirements for applications, labeling, and postmarketing reporting.
* Recognize the implications of the delayed effective date and the reasons for the delay.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Additional information
| Federal Register Title | Nonprescription Drug Product With an Additional Condition for Nonprescription Use. Document Number: 2025-04978 |
|---|---|
| Course SKU | FR-25-1280-1 |
| Why This Course Is Important | By not taking this course, you risk non-compliance with the FDA's critical regulatory standards, potentially leading to application rejections and legal issues. |